Loading...
Groups source: ARIS

Chair for Pharmaceutical Chemistry

Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   

Code Science Field
P390  Natural sciences and mathematics  Organic chemistry 
P310  Natural sciences and mathematics  Proteins, enzymology 
B740  Biomedical sciences  Pharmacological sciences, pharmacognosy, pharmacy, toxicology 
T490  Technological sciences  Biotechnology 
Keywords
Pharmaceutical chemistry, active substances, selective ligands, peptidomimetics, radicals, reactions of radicals, nitroxides, spin markers, electron spin resonance, biotechnology, recombinant proteins, steroids, inhibitors, eukariotics organisms, prokariotics organisms, analyses of biospecimens.
Evaluation (rules)
source: COBISS
Points
33,832.19
A''
5,239.93
A'
16,946.37
A1/2
23,099.43
CI10
39,745
CImax
1,095
h10
81
A1
119.34
A3
27.83
Data for the last 5 years (citations for the last 10 years) on April 23, 2024; A3 for period 2018-2022
Database Linked records Citations Pure citations Average pure citations
WoS 2,216  54,040  46,974  21.2 
Scopus 2,253  59,982  52,497  23.3 
Researchers (104)
no. Code Name and surname Research area Status No. of publicationsNo. of publications
1.  58954  Boštjan Adamlje  Pharmacy  Researcher 
2.  21456  PhD Marko Anderluh  Pharmacy  Researcher  371 
3.  24257  PhD Aleš Berlec  Pharmacy  Researcher  218 
4.  00781  PhD Borut Božič  Microbiology and immunology  Researcher  601 
5.  23598  PhD Tomaž Bratkovič  Pharmacy  Researcher  235 
6.  53656  PhD Aleša Bricelj  Pharmacy  Researcher  32 
7.  57938  Tilen Burnik  Pharmacy  Researcher 
8.  26227  Manja Cedilnik    Junior expert or technical associate 
9.  37459  PhD Andrej Emanuel Cotman  Chemistry  Researcher  57 
10.  19281  PhD Zdenko Časar  Chemistry  Researcher  166 
11.  15099  PhD Darko Černe  Pharmacy  Researcher  261 
12.  16362  PhD Saša Čučnik  Microbiology and immunology  Researcher  386 
13.  54784  Jaka Dernovšek  Pharmacy  Researcher  29 
14.  19785  PhD Bojan Doljak  Pharmacy  Researcher  257 
15.  57579  Ivan Džajić  Pharmacy  Researcher 
16.  55890  Svit Ferjančič Benetik  Pharmacy  Researcher 
17.  31879  Petra Ferkov    Junior expert or technical associate 
18.  57970  MSc Marzia Fois  Pharmacy  Researcher 
19.  34841  Maja Frelih  Forestry, wood and paper technology  Junior expert or technical associate  16 
20.  26512  PhD Rok Frlan  Pharmacy  Researcher  113 
21.  50713  Katja Glinšek  Pharmacy  Researcher 
22.  58034  Klemen Gnidovec  Pharmacy  Researcher 
23.  32034  PhD Martina Gobec  Oncology  Researcher  178 
24.  15284  PhD Stanislav Gobec  Pharmacy  Researcher  837 
25.  58037  Nina Gradišek  Pharmacy  Researcher 
26.  52379  PhD Samo Guzelj  Pharmacy  Researcher  22 
27.  57412  Danijela Herga  Pharmacy  Researcher 
28.  54604  Luka Hiti  Pharmacy  Researcher 
29.  55893  Selena Horvat  Pharmacy  Researcher 
30.  32036  PhD Martina Hrast Rambaher  Pharmacy  Researcher  129 
31.  24400  PhD Janez Ilaš  Pharmacy  Researcher  246 
32.  26496  PhD Žiga Jakopin  Pharmacy  Researcher  195 
33.  56838  Špela Janež  Pharmacy  Researcher 
34.  01302  PhD Matjaž Jeras  Biotechnology  Researcher  363 
35.  56841  Ana Jug  Pharmacy  Researcher 
36.  27741  PhD Simona Jurković Mlakar  Pharmacy  Researcher  84 
37.  18619  PhD Maša Kandušer  Pharmacy  Researcher  160 
38.  21459  PhD Nataša Karas Kuželički  Pharmacy  Researcher  172 
39.  56840  Vid Kavaš  Pharmacy  Researcher 
40.  21692  Irena Klančnik Mavec    Junior expert or technical associate 
41.  36438  PhD Damijan Knez  Pharmacy  Researcher  198 
42.  26495  PhD Nina Kočevar Glavač  Pharmacy  Researcher  237 
43.  55892  Anja Kodila  Pharmacy  Researcher 
44.  30815  PhD Meta Kokalj Ladan  Pharmacy  Researcher  33 
45.  04648  PhD Janko Kos  Biotechnical sciences  Researcher  1,159 
46.  33908  PhD Urban Košak  Pharmacy  Researcher  58 
47.  55572  PhD Alen Krajnc  Pharmacy  Researcher  32 
48.  15460  PhD Samo Kreft  Pharmacy  Researcher  779 
49.  19649  PhD Marija Nika Lovšin  Microbiology and immunology  Researcher  124 
50.  57531  David Lukić  Pharmacy  Researcher 
51.  25096  PhD Mojca Lunder  Pharmacy  Researcher  254 
52.  12189  PhD Janja Marc  Metabolic and hormonal disorders  Researcher  712 
53.  34223  PhD Tijana Markovič  Pharmacy  Researcher  58 
54.  58033  Peter Mastnak-Sokolov  Pharmacy  Researcher 
55.  53777  Mateja Matjaž    Junior expert or technical associate 
56.  36440  PhD Ana Mitrović  Pharmacy  Researcher  112 
57.  12443  PhD Irena Mlinarič Raščan  Pharmacy  Researcher  533 
58.  23419  PhD Janez Mravljak  Pharmacy  Researcher  201 
59.  19061  PhD Aleš Obreza  Pharmacy  Researcher  331 
60.  32693  PhD Jasna Omersel  Pharmacy  Researcher  89 
61.  10691  PhD Joško Osredkar  Human reproduction  Researcher  1,306 
62.  18154  PhD Barbara Ostanek  Metabolic and hormonal disorders  Researcher  188 
63.  28861  PhD Stane Pajk  Pharmacy  Researcher  189 
64.  57678  Emiliano Paradiso  Pharmacy  Researcher 
65.  19170  PhD Urša Pečar Fonović  Pharmacy  Researcher  145 
66.  37648  Katja Perc    Junior expert or technical associate  11 
67.  26104  Peter Peršolja  Pharmacy  Researcher 
68.  19317  PhD Lucija Peterlin Mašič  Pharmacy  Researcher  407 
69.  55894  Martina Piga  Pharmacy  Researcher  11 
70.  32035  PhD Anja Pišlar  Biotechnology  Researcher  166 
71.  51651  PhD Tina Vida Plavec  Biotechnology  Researcher  51 
72.  52376  PhD Matic Proj  Pharmacy  Researcher  65 
73.  55895  Edvin Purić  Pharmacy  Researcher 
74.  30708  PhD Petra Ratajc  Pharmacy  Researcher  16 
75.  29603  PhD Matjaž Ravnikar  Pharmacy  Researcher  70 
76.  58036  Žana Rus  Metabolic and hormonal disorders  Researcher 
77.  54785  Katja Schoss  Pharmacy  Researcher  29 
78.  58611  PhD Daniela Secci  Pharmacy  Researcher 
79.  19786  Majda Sirnik    Junior expert or technical associate 
80.  57309  Tjaša Slokan  Pharmacy  Researcher 
81.  55140  Lara Smrdel  Pharmacy  Researcher  12 
82.  08519  PhD Marija Sollner Dolenc  Pharmacy  Researcher  658 
83.  30816  PhD Izidor Sosič  Pharmacy  Researcher  251 
84.  25490  PhD Matej Sova  Pharmacy  Researcher  163 
85.  52378  Nika Strašek Benedik  Pharmacy  Researcher  26 
86.  29982  PhD Alenka Šmid  Pharmacy  Researcher  123 
87.  07849  PhD Borut Štrukelj  Biochemistry and molecular biology  Researcher  1,125 
88.  26198  PhD Urban Švajger  Microbiology and immunology  Researcher  204 
89.  33335  PhD Eva Tavčar  Pharmacy  Researcher  79 
90.  35325  Martina Tekavec    Junior expert or technical associate 
91.  57679  PhD Mateja Toma  Pharmacy  Researcher 
92.  28334  PhD Tihomir Tomašić  Pharmacy  Researcher  374 
93.  58038  Gašper Tomšič  Pharmacy  Researcher  10 
94.  34512  PhD Dunja Urbančič  Pharmacy  Researcher  59 
95.  01878  PhD Uroš Urleb  Pharmacy  Researcher  380 
96.  53726  Lucija Ana Vrščaj  Metabolic and hormonal disorders  Researcher  31 
97.  54787  Veronika Weiss  Pharmacy  Researcher 
98.  53670  PhD Živa Zajec  Pharmacy  Researcher  15 
99.  17438  Damijana Zalar    Junior expert or technical associate 
100.  53234  MSc Maja Zalokar  Natural sciences and mathematics  Junior expert or technical associate  44 
101.  18633  PhD Anamarija Zega  Pharmacy  Researcher  186 
102.  28905  PhD Nace Zidar  Pharmacy  Researcher  219 
103.  32306  PhD Janja Zupan  Metabolic and hormonal disorders  Researcher  110 
104.  58035  Ana Zupančič  Pharmacy  Researcher 
Research projects (74) Legend
no. Code Title Period Head of the group No. of publicationsNo. of publications
1.  J1-1717  Development of novel Hsp90 inhibitors with anticancer activity  7/1/2019 - 6/30/2023  PhD Tihomir Tomašić  1,893 
2.  J3-1745  Elucidating the role of immunoproteasome in platelet-driven immune response  7/1/2019 - 6/30/2023  PhD Martina Gobec  1,122 
3.  J3-1749  Mesenchymal stem cells-the keepers of tissue endogenous regenerative capacity facing up to aging of the musculoskeletal system  7/1/2019 - 6/30/2023  PhD Janja Zupan  2,345 
4.  J3-1759  Comprehensive characterization of GWAS hits – pipeline to novel drug targets for anabolic treatment of osteoporosis (GWASforAna)  7/1/2019 - 6/30/2022  PhD Janja Marc  4,735 
5.  J3-9256  Development of NOD2 agonists and dual NOD2/TLR7 agonistic conjugates as novel vaccine adjuvants  7/1/2018 - 6/30/2022  PhD Žiga Jakopin  2,803 
6.  Z1-1859  Targeted covalent inhibitors: inhibiting monoamine oxidase through non-catalytic amino-acid residues  7/1/2019 - 6/30/2021  PhD Damijan Knez  198 
7.  J3-9267  Inhibition of cathepsin X activity as a novel strategy for the treatment of Parkinson's disease   7/1/2018 - 6/30/2021  PhD Anja Pišlar  2,723 
8.  J1-9192  New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors   7/1/2018 - 6/30/2021  PhD Lucija Peterlin Mašič  2,193 
9.  J4-9327  Targeting, imaging and treating of colorectal cancer with safe theranostic bacteria  7/1/2018 - 6/30/2021  PhD Aleš Berlec  2,468 
10.  N1-0068  Identification of non-peptidic inhibitors of the immunoproteasome using fragment based drug discovery methods  11/1/2017 - 10/31/2020  PhD Stanislav Gobec  1,803 
11.  Z1-9195  Butyrylcholinesterase inhibitors for alleviating symptoms of Alzheimer's disease  7/1/2018 - 6/30/2020  PhD Urban Košak  58 
12.  NC-0004  NOBIL - Novel Biomarkers in Leukemia  5/1/2018 - 4/30/2020  PhD Irena Mlinarič Raščan  775 
13.  J4-8227  Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy   5/1/2017 - 4/30/2020  PhD Janko Kos  4,553 
14.  L1-8157  Development of multifunctional compounds for treatment of Alzheimer's disease  5/1/2017 - 4/30/2020  PhD Stanislav Gobec  4,690 
15.  J1-8145  Dynamic aspect of ligand-protein binding  5/1/2017 - 4/30/2020  PhD Simona Golič Grdadolnik  1,749 
16.  J1-8140  Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard in zdravje ljudi  5/1/2017 - 4/30/2020  PhD Metka Filipič  3,735 
17.  J1-8152  Inhibition of Staphylococcus aureus cell wall remodeling  5/1/2017 - 4/30/2020  PhD Dušan Turk  1,976 
18.  J3-8207  New frontiers in folate supplementation in obstetrics and gynaecology (NFFS OB-GYN)  5/1/2017 - 4/30/2020  PhD Ksenija Geršak  4,975 
19.  J3-8210  Potential of low, sub-therapeutic doses of statins and sartans in primary and secondary cardiovascular disease prevention  5/1/2017 - 4/30/2020  PhD Mirza Šabovič  2,432 
20.  Z1-8158  Discovery of new inhibitors of bacterial peptidoglycan biosynthesis enzymes MurA and MurB  5/1/2017 - 4/30/2019  PhD Marko Jukič  171 
21.  J3-7245  Identification of new expression regulators of RANKL, a key molecule not only in bone remodelling  1/1/2016 - 12/31/2018  PhD Janja Marc  2,689 
22.  J1-7515  Receptors for toxins of plant pathogens  1/1/2016 - 12/31/2018  PhD Gregor Anderluh  3,836 
23.  J1-7479  Structural insight into iodine metabolism  1/1/2016 - 12/31/2018  PhD Dušan Turk  1,765 
24.  V3-1636  New psychoactive substances monitoring system in Slovenia (acronym SONDA)  10/1/2016 - 9/30/2018  PhD Miran Brvar  1,488 
25.  Z1-7181  Optimization of nitroxoline-based inhibitors of cathepsin B as potential drugs for the treatment of cancer  1/1/2016 - 12/31/2017  PhD Izidor Sosič  251 
26.  L1-6745  Combating bacterial resistance: optimisation of bacterial cell wall biosynthesis inhibitors  7/1/2014 - 6/30/2017  PhD Stanislav Gobec  3,233 
27.  J1-6743  Computational tools development for modeling of pharmaceutically interesting molecules  7/1/2014 - 6/30/2017  PhD Dušanka Janežič  2,705 
28.  J4-6811  The role of cysteine protease inhibitors in NK cell mediated lysis of tumour cells  7/1/2014 - 6/30/2017  PhD Janko Kos  2,438 
29.  J3-6792  TRANS TIO Translational pharmacogenomic research of thiopurine therapy  7/1/2014 - 6/30/2017  PhD Irena Mlinarič Raščan  1,598 
30.  J3-5507  ANALYSIS OF FOLATE METABOLISM BIOMARKERS IN THE RISK ASSESSMENT FOR NEURAL TUBE DEFECTS  8/1/2013 - 7/31/2016  PhD Ksenija Geršak  3,611 
31.  J3-5502  Dysregulation of TDP-43 expression in amyotrophic lateral sclerosis and frontotemporal lobar degeneration  8/1/2013 - 7/31/2016  PhD Boris Rogelj  5,277 
32.  J3-5511  Micro RNA – new diagnostic and therapeutic targerts in osteoporosis  8/1/2013 - 7/31/2016  PhD Janez Preželj  1,718 
33.  J4-5529  Nitroxoline and its derivatives as new antitumour drugs  8/1/2013 - 7/31/2016  PhD Janko Kos  5,950 
34.  J1-5450  Protein engineering of recombinant probiotic lactic acid bacteria for treatment of irritative bowel disease  8/1/2013 - 7/31/2016  PhD Borut Štrukelj  2,442 
35.  Z1-5458  Design, synthesis, and evaluation of new voltage-gated sodium channels modulators  8/1/2013 - 7/31/2015  PhD Nace Zidar  219 
36.  J3-4285  Development and evaluation of radiolabelled bio-molecules for targeted radionuclide therapy and imaging of neuroendocrine tumours  7/1/2011 - 6/30/2014  PhD Jurij Fettich  2,352 
37.  L1-4039  Preclinical development of new antibacterial drugs  7/1/2011 - 6/30/2014  PhD Stanislav Gobec  4,141 
38.  J3-4220  The role of genetic polymorphisms in treatment result and occurance of side effects in children with cancer  7/1/2011 - 6/30/2014  PhD Janez Jazbec  3,350 
39.  J3-3615  Pharmacogenetic approaches to research, diagnosis and therapy of leukemia  5/1/2010 - 4/30/2013  PhD Irena Mlinarič Raščan  2,121 
40.  J3-2330  Genetski dejavniki pri osteoporozi (Slovene)  5/1/2009 - 4/30/2012  PhD Janja Marc  2,289 
41.  J4-2212  Glivni citokromi P450, vključeni v detoksifikacijo rastlinskih obramnih spojin, kot tarče novih protiglivnih učinkovin (Slovene)  5/1/2009 - 4/30/2012  PhD Nada Kraševec  3,742 
42.  J3-2356  Izrazanje in funkcionalna analiza nekodirajocih RNA pri parkinsonovi bolezni (Slovene)  5/1/2009 - 4/30/2012  PhD Boris Rogelj  4,362 
43.  L3-2293  Zaščitni pleiotropni učinki nizkih odmerkov zaviralcev sistema renin-angiotenzin in statinov pri zdravi populaciji srednjih let (Slovene)  5/1/2009 - 4/30/2012  PhD Mirza Šabovič  3,691 
44.  L3-0129  Cell-free nucleic acids in diagnosis of coronary atherosclerosis  2/1/2008 - 1/30/2011  PhD Darko Černe  2,043 
45.  J7-0337  Formulation and characterization of fuzogenic colloidal nanoparticles for efficient drug delivery into cells  2/1/2008 - 1/30/2011  PhD Marjeta Šentjurc  1,541 
46.  J3-0488  Functional analysis of non-coding RNAs in Parkinson's disease  2/1/2008 - 1/30/2011  PhD Boris Rogelj  2,339 
47.  L3-0431  Genetics of breast cancer and hormone replacement therapy  2/1/2008 - 1/30/2011  PhD Ksenija Geršak  3,745 
48.  J7-0474  New Report on Condition of Knowledge in Developed Societies – 30 Years after Jean-François Lyotard’s Analysisew Report on Knowledge  2/1/2008 - 1/30/2011  PhD Mladen Dolar  3,154 
49.  L4-1046  NOVEL BIOTECH DRUG SUBSTANCES BY USING PHAGE DISPLAY TECHNOLOGY  2/1/2008 - 1/30/2011  PhD Borut Štrukelj  3,940 
50.  L3-0636  Preparation and evaluation of stabilised control blood for haematology analysers in Slovenian external quality assessment scheme (SNEQAS).  2/1/2008 - 1/30/2011  PhD Milan Skitek  1,138 
51.  J4-9425  Lectins as modulators of anti-tumour immune response  1/1/2007 - 12/31/2009  PhD Janko Kos  2,213 
52.  J4-7062  Proteomics as a tool for monitoring biosynthesis processes  9/1/2005 - 8/31/2008  PhD Janko Kos  5,974 
53.  J1-7363  Role of the proteolytic systems in the malignancy of brain tumour stem cells.  9/1/2005 - 8/31/2008  PhD Irena Zajc  3,433 
54.  J3-7406  Thiopurine pharmacogenetics - novel diagnostics and individualized therapy   9/1/2005 - 8/31/2008  PhD Irena Mlinarič Raščan  2,594 
55.  M4-0124  Prehranski dodatki za optimalno prehrano v ekstremnih razmerah (Slovene)  6/1/2006 - 11/30/2007  PhD Samo Kreft  4,015 
56.  L1-6707  Design, synthesis and test of potencial hypolipidemic drugs with a new target  2/1/2004 - 1/30/2007  PhD Uroš Urleb  3,381 
57.  L1-6711  Development of a technological procedure for preparation of biologicaly active hop extract enriched with xanthohumol  7/1/2004 - 6/30/2006  PhD Tamara Lah Turnšek  5,930 
58.  Z1-6451  Mehanizem povečanja permeabilnosti sečnega mehurja s hitosanom (Slovene)  7/1/2004 - 6/30/2006  PhD Danijel Kikelj  810 
59.  Z4-6096  Peptide ligands as novel biopharmaceutics by using phage display technology  2/1/2004 - 1/30/2006  PhD Borut Štrukelj  1,344 
60.  L1-5267  Analysis of gene expression associated with apoptosis using microarrays  1/1/2003 - 12/31/2005  PhD Irena Mlinarič Raščan  717 
61.  L3-5309  Analysis of gene expression associated with apoptosis using microarrays  1/1/2003 - 12/31/2005  PhD Irena Mlinarič Raščan  1,130 
62.  L3-5084  Peptidominetiki - inhibitorji koagulacije krvi in agregacije trombocitov (Slovene)  1/1/2003 - 12/31/2005  PhD Mojca Stegnar  5,536 
63.  L4-4090  Optimizacija kakovosti zdravilnih rastlin (Echinacea purpurea Moench., Gentiana lutea L., Hypericum perforatum L.) v pridelovanju (Slovene)  7/1/2002 - 6/30/2005  PhD Dea Baričevič  2,414 
64.  Z1-3238  Genetic and environmental risk factors for bone remodelation disturbances  7/1/2001 - 6/30/2004  PhD Samo Kreft  2,081 
65.  J3-3395  Genetic causes of female infertility 2   7/1/2001 - 6/30/2004  PhD Ksenija Geršak  4,575 
66.  J3-3314  Genetic factors and hormones in metabolic diseases  7/1/2001 - 6/30/2004  PhD Andreja Kocijančič  4,934 
67.  L3-2003  Razvoj rutinskih metod za dolocanje presnovkov galaktoze in genotipizacijo galaktozemij (Slovene)  1/1/2000 - 6/30/2002  PhD Tadej Battelino  3,067 
68.  L4-1301  Proučevanje aktualnih kužnih bolezni pri živalih z uporabo sodobnih imunoloških, biokemijskih in molekularnih metod (Slovene)  1/1/1999 - 6/30/2001  PhD Darja Barlič Maganja  8,856 
69.  L4-0827  Tkivne kulture za proizvodnjo sekundarnih metabolitov (Slovene)  7/1/1998 - 6/30/2001  PhD Jana Žel  3,102 
70.  V4-9128  Uporaba rastlinske biotehnologije za varstvo rastlin (razvoj identifikacijskih metod za rastlinske patogene in ovrednotenje transgenih (Slovene)  10/1/1997 - 9/30/2000  PhD Maja Ravnikar  6,455 
71.  L1-0469  Optimization of MDP and TNF analogues having therapeutic potential  7/1/1998 - 6/30/2000  PhD Anton Štalc  6,234 
72.  J1-8889  Mimetics of biologically active peptides: Strategies of design and synthesis  1/1/1997 - 12/31/1999  PhD Danijel Kikelj  3,849 
73.  L4-7355  Alternativno koriščenje za slovenijo perspektivnih zdravilnih in aromatičnih rastlin in njihovo vrednotenje (Slovene)  1/1/1996 - 12/31/1998  PhD Dea Baričevič  1,662 
74.  L1-7379  Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene)  1/1/1996 - 6/30/1998  PhD Anton Štalc  6,015 
ARIS research and infrastructure programmes (11) Legend
no. Code Title Period Head of the group No. of publicationsNo. of publications
1.  P1-0208  Medicinal chemistry - drug design, synthesis and evaluation  1/1/2015 - 12/31/2021  PhD Stanislav Gobec  5,971 
2.  I0-0022  Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL) (Slovene)  1/1/2015 - 12/31/2021  PhD Anton Ramšak  13,477 
3.  P3-0298  Genes, hormones and personality changes in metabolic disorders  1/1/2015 - 12/31/2018  PhD Andrej Janež  4,841 
4.  P4-0127  Pharmaceutical biotechnology: Science for Health  1/1/2015 - 12/31/2018  PhD Janko Kos  4,940 
5.  P4-0127  Farmacevtska biotehnologija: znanje za zdravje (Slovene)  1/1/2009 - 12/31/2014  PhD Janko Kos  5,416 
6.  P1-0208  Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)  1/1/2009 - 12/31/2014  PhD Danijel Kikelj  5,844 
7.  P3-0298  Genes, hormones and mental changes in metabolic disorders  1/1/2009 - 12/31/2014  PhD Janez Preželj  4,570 
8.  P3-0298  Genes, hormones and mental changes in metabolic disorders  7/1/2004 - 12/31/2008  PhD Janez Preželj  3,889 
9.  P1-0208  Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)  1/1/2004 - 12/31/2008  PhD Danijel Kikelj  6,002 
10.  P4-0127  Pharmaceutical biotechnology: man and environment  1/1/2004 - 12/31/2008  PhD Janko Kos  5,248 
11.  P0-0502-0787  Farmacevtska kemija (Slovene)  1/1/1999 - 12/31/2003  PhD Danijel Kikelj  7,521 
Views history
Favourite